|
Indirect comparison of aflibercept with ranibizumab prn and bevacizumab prn in wet age-related macular degeneration.
Third-party funded project |
Project title |
Indirect comparison of aflibercept with ranibizumab prn and bevacizumab prn in wet age-related macular degeneration. |
Principal Investigator(s) |
Bucher, Heiner
|
Organisation / Research unit |
Departement Klinische Forschung / Klinische Epidemiologie (Bucher H) |
Project start |
01.08.2011 |
Probable end |
31.12.2011 |
Status |
Completed |
Abstract |
Project which aims to assess in a first step whether an indirect comparison of aflibercept with ranibizumab prn and bevacizumab prn in wet age-related macular degeneration is feasible. If an indirect is feasible based on the data available a network analysis will be performed in a second step. |
Financed by |
Other sources
|
|
|
|
MCSS v5.8 PRO. 0.672 sec, queries - 0.000 sec
©Universität Basel | Impressum
| |
05/05/2024
Research Database / FORSCHUNGSDATENBANK
|